Usefulness of quantifying serum KL-6 levels in the follow-up of uveitic patients with sarcoidosis

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 244, Issue 4, 2006, Pages 433-437

  Kitaichi, Nobuyoshi ^a   Ariga, Toshihide ^a   Kase, Satoru ^a   Yoshida, Kauzhiko ^a   Namba, Kenichi ^a   Ohno, Shigeaki ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCOPROTEIN; IMIDAPRIL; PREDNISOLONE; PROTEIN KL 6; UNCLASSIFIED DRUG; VALSARTAN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; IMMUNOASSAY; MALE; MONITORING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SARCOIDOSIS; UVEITIS; VOLUNTEER;

ADULT; AGED; ANTIGENS, NEOPLASM; ANTIHYPERTENSIVE AGENTS; BIOLOGICAL MARKERS; CHEMILUMINESCENT MEASUREMENTS; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; MUCIN-1; MUCINS; PEPTIDYL-DIPEPTIDASE A; SARCOIDOSIS, PULMONARY; UVEITIS;

EID: 33645776005     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-005-0081-9     Document Type: Article

References (34)

1. Ashida T, Higashishiba M, Sumimoto Y, Sano T, Miyazato H, Shimada T, Miyatake J, Kawanishi K, Tatsumi Y, Kanamaru A (2001) Serum KL-6 levels in patients with pulmonary complications after allogeneic bone marrow transplantation. Int J Hematol 74:464-468
2. Berry M, Ellingham RB, Corfield AP (2000) Membrane-associated mucins in normal human conjunctiva. Invest Ophthalmol Vis Sci 41:398-403
3. Endoh Y, Hanai R, Uto K, Uno M, Nagashima H, Narimatsu A, Takizawa T, Onishi S, Kasanuki H (2000) KL-6 as a potential new marker for amiodarone-induced pulmonary toxicity. Am J Cardiol 86:229-231
4. Goda C, Kotake S, Sasamoto Y, Yoshikawa K, Okamoto T, Matsuda H (1998) Clinical manifestations and diagnosis of patients with sarcoidosis. Nippon Ganka Gakkai Zasshi 102:106-110
5. Hamada H, Kohno N, Akiyama M, Hiwada K (1992) Monitoring of serum KL-6 antigen in a patient with radiation pneumonia. Chest 101:858-860
6. Hamada H, Kohno N, Yokoyama A, Hirasawa Y, Hiwada K, Sakatani M, Ueda E (1998) KL-6 as a serologic indicator of Pneumocystis carinii pneumonia in immunocompromised hosts. Intern Med 37:307-310
7. Hayashi Y, Kao WW, Kohno N, Nishihara-Hayashi M, Shiraishi A, Uno T, Yamaguchi M, Okamoto S, Maeda M, Ikeda T, Hamada H, Kondo K, Ohashi Y (2004) Expression patterns of sialylated epitope recognized by KL-6 monoclonal antibody in ocular surface epithelium of normals and dry eye patients. Invest Ophthalmol Vis Sci 45:2212-2217
8. Henderly DE, Genstler AJ, Smith RE, Rao NA (1987) Changing patterns of uveitis. Am J Ophthalmol 103:131-136
9. Hiraga Y (1989) Annual report of diffuse lung disease research committee. The Ministry of Health and Welfare, Tokyo
10. Hirasawa Y, Kohno N, Yokoyama A, Inoue Y, Abe M, Hiwada K (1997) KL-6, a human MUC1 mucin, is chemotactic for human fibroblasts. Am J Respir Cell Mol Biol 17:501-507
11. Imai T, Takase M, Takeda S, Kougo T (2002) Serum KL-6 levels in pediatric patients: Reference values for children and levels in pneumonia, asthma, and measles patients. Pediatr Pulmonol 33:135-141
12. Inatomi T, Spurr-Michaud S, Tisdale AS, Gipson IK (1995) Human corneal and conjunctival epithelia express MUC1 mucin. Invest Ophthalmol Vis Sci 36:1818-1827
13. Jabs DA, Johns CJ (1986) Ocular involvement in chronic sarcoidosis. Am J Ophthalmol 102:297-301
14. James DG, Neville E, Langley DA (1976) Ocular sarcoidosis. Trans Ophthalmol Soc U K 96:133-139
15. Kijlstra A, Rothova A, Baarsma GS, Zaal MJ, Fortuin ME, Schweitzer C, Glasius E, de Jong PT (1987) Computer registration of uveitis patients. Doc Ophthalmol 67:139-143
16. Kitaichi N, Kotake S, Mizue Y, Matsuda H, Onoé K, Nishihira J (2000) Increase of macrophage migration inhibitory factor in sera of patients with iridocyclitis. Br J Ophthalmol 84:1423-1425
17. Kitaichi N, Kotake S, Mizue Y, Sasamoto Y, Goda C, Iwabuchi K, Onoé K, Matsuda H, Nishihira J (2000) High-dose corticosteroid administration induces increase of serum macrophage migration inhibitory factor in patients with Vogt-Koyanagi-Harada's disease. Microbiol Immunol 44:1075-1077
18. Kitaichi N, Kotake S, Sasamoto Y, Namba K, Matsuda A, Ogasawara K, Onoé K, Matsuda H, Nishihira J (1999) Prominent increase of macrophage migration inhibitory factor in the sera of patients with uveitis. Invest Ophthalmol Vis Sci 40:247-250
19. Kitaichi N, Kotake S, Shibuya H, Yamada Y, Chiba H, Namba K, Ohno S (2003) Increase of KL-6 in sera of uveitis patients with sarcoidosis. Graefes Arch Clin Exp Ophthalmol 241:879-883
20. Kobayashi J, Kitamura S (1995) KL-6: A serum marker for interstitial pneumonia. Chest 108:311-315
21. Kobayashi J, Kitamura S (1996) Serum KL-6 for the evaluation of active pneumonitis in pulmonary sarcoidosis. Chest 109:1276-1282
22. Kohno N, Akiyama M, Kyoizumi S, Hakoda M, Kobuke K, Yamakido M (1988) Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies, KL-3 and KL-6, against lung adenocarcinoma. Jpn J Clin Oncol 18:203-216
23. Kotake S, Furudate N, Sasamoto Y, Yoshikawa K, Goda C, Matsuda H (1996) Characteristics of endogenous uveitis in Hokkaido, Japan. Graefes Arch Clin Exp Ophthalmol 234:599-603
24. Kotake S, Kitaichi N, Ohno S (2002) Macrophage migration inhibitory factor in uveitis. Int Ophthalmol Clin 42:99-103
25. Nakajima H, Harigai M, Hara M, Hakoda M, Tokuda H, Sakai F, Kamatani N, Kashiwazaki S (2000) KL-6 as a novel serum marker for interstitial pneumonia associated with collagen diseases. J Rheumatol 27:1164-1170
26. Narita M, Nakayama M, Yamada S, Togashi T (2001) Elevated KL-6 levels in fatal measles pneumonia. Eur J Pediatr 160:454-455
27. Narita M, Tanaka H, Abe S, Yamada S, Kubota M, Togashi T (2000) Close association between pulmonary disease manifestation in Mycoplasma pneumoniae infection and enhanced local production of interleukin-18 in the lung, independent of gamma interferon. Clin Diagn Lab Immunol 7:909-914
28. Obenauf CD, Shaw HE, Sydnor CF, Klintworth GK (1978) Sarcoidosis and its ophthalmic manifestations. Am J Ophthalmol 86:648-655
29. Ogawa Y, Ishikawa T, Ikeda K, Nakata B, Sawada T, Ogisawa K, Kato Y, Hirakawa K (2000) Evaluation of serum KL-6, a mucin-like glycoprotein, as a tumor marker for breast cancer. Clin Cancer Res 6:4069-4072
30. Rolf A, Walter R, Hans P, Thomas S (1994) Third International Workshop on Lung Tumor and Differential Antigens: Overview of the results of the central data analysis. Int J Cancer (Suppl) 8:8-26
31. Rothova A (2000) Ocular involvement in sarcoidosis. Br J Ophthalmol 84:110-116
32. Semenzato G, Bortoli M, Agostini C (2002) Applied clinical immunology in sarcoidosis. Curr Opin Pulm Med 8:441-444
33. Tran VT, Auer C, Guex-Crosier Y, Pittet N, Herbort CP (1994) Epidemiological characteristics of uveitis in Switzerland. Int Ophthalmol 18:293-298
34. Uyama M (2002) Uveitis in sarcoidosis. Int Ophthalmol Clin 42:143-150